Association between the ABCG2 C421A polymorphism and Alzheimer's disease

被引:37
作者
Feher, Agnes [1 ]
Juhasz, Anna [1 ]
Laszlo, Anna [2 ]
Pakaski, Magdolna [1 ]
Kalman, Janos [1 ]
Janka, Zoltan [1 ]
机构
[1] Univ Szeged, Dept Psychiat, H-6724 Szeged, Hungary
[2] Univ Szeged, Dept Med Phys & Informat, H-6720 Szeged, Hungary
关键词
Alzheimer's disease; ATP binding cassette subfamily G member 2 (ABCG2); Breast cancer resistance protein (BCRP); ABCG2 C421A (rs2231142); Single nucleotide polymorphism (SNP); BLOOD-BRAIN-BARRIER; AMYLOID-BETA; TRANSPORTER ABCG2; P-GLYCOPROTEIN; MOUSE MODEL; PROTEIN; BCRP; EXPRESSION; RESISTANCE; VARIANTS;
D O I
10.1016/j.neulet.2013.06.044
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
ATP binding cassette subfamily G member 2 (ABCG2) is involved in amyloid-beta transport and was found to be significantly up-regulated in Alzheimer's disease (AD) brain. A functional polymorphism of the ABCG2 gene (C421A; rs2231142) was genotyped in a sample of 299 Hungarian late-onset AD patients and 259 elderly, non-demented controls to investigate for the first time its association with AD, either alone or in combination with apolipoprotein E (APOE) epsilon 2/epsilon 3/epsilon 4 polymorphism. A significantly increased susceptibility to AD (OR= 1.741, 95% CI: 1.075-2.819, p = 0.024) associated with ABCG2 C/C genotype was found when compared with the variant allele containing genotypes (CA and AA) as the reference category. Logistic regression analysis revealed a significant interaction effect between the ABCG2 C/C genotype and APOE epsilon 4 allele on AD risk (p = 0.003). It seems that the potential modest risk effect of the ABCG2 C/C genotype on AD risk is more pronounced in combination with the APOE epsilon 4 allele. Further independent replications of our findings are required. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:51 / 54
页数:4
相关论文
共 31 条
[1]  
[Anonymous], STAT POWER ANAL BEHA
[2]   The blood-brain barrier: an overview - Structure, regulation, and clinical implications [J].
Ballabh, P ;
Braun, A ;
Nedergaard, M .
NEUROBIOLOGY OF DISEASE, 2004, 16 (01) :1-13
[3]   P-glycoprotein deficiency at the blood-brain barrier increases amyloid-β deposition in an Alzheimer disease mouse model [J].
Cirrito, JR ;
Deane, R ;
Fagan, AM ;
Spinner, ML ;
Parsadanian, M ;
Finn, MB ;
Jiang, H ;
Prior, JL ;
Sagare, A ;
Bales, KR ;
Paul, SM ;
Zlokovic, BV ;
Piwnica-Worms, D ;
Holtzman, DM .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (11) :3285-3290
[4]   The number of trait loci in late-onset Alzheimer disease [J].
Daw, EW ;
Payami, H ;
Nemens, EJ ;
Nochlin, D ;
Bird, TD ;
Schellenberg, GD ;
Wijsman, EM .
AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 66 (01) :196-204
[5]   ABCG2 pharmacogenetics: Ethnic differences in allele frequency and assessment of influence on irinotecan disposition [J].
de Jong, FA ;
Marsh, S ;
Mathijssen, RHJ ;
King, C ;
Verweij, J ;
Sparreboom, A ;
McLeod, HL .
CLINICAL CANCER RESEARCH, 2004, 10 (17) :5889-5894
[6]   apoE isoform-specific disruption of amyloid β peptide clearance from mouse brain [J].
Deane, Rashid ;
Sagare, Abhay ;
Hamm, Katie ;
Parisi, Margaret ;
Lane, Steven ;
Finn, Mary Beth ;
Holtzman, David M. ;
Zlokovic, Berislav V. .
JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (12) :4002-4013
[7]   Plaque-associated disruption of CSF and plasma amyloid-β (Aβ) equilibrium in a mouse model of Alzheimer's disease [J].
DeMattos, RB ;
Bales, KR ;
Parsadanian, M ;
O'Dell, MA ;
Foss, EM ;
Paul, SM ;
Holtzman, DM .
JOURNAL OF NEUROCHEMISTRY, 2002, 81 (02) :229-236
[8]   Apolipoprotein E, amyloid-β, and blood-brain barrier permeability in Alzheimer disease [J].
Donahue, John E. ;
Johanson, Conrad E. .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2008, 67 (04) :261-270
[9]   RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease [J].
Donahue, John E. ;
Flaherty, Stephanie L. ;
Johanson, Conrad E. ;
Duncan, John A., III ;
Silverberg, Gerald D. ;
Miller, Miles C. ;
Tavares, Rosemarie ;
Yang, Wentian ;
Wu, Qian ;
Sabo, Edmond ;
Hovanesian, Virginia ;
Stopa, Edward G. .
ACTA NEUROPATHOLOGICA, 2006, 112 (04) :405-415
[10]   No association between CALHM1 polymorphism and Alzheimer's disease risk in a Hungarian population [J].
Feher, Agnes ;
Juhasz, Anna ;
Rimanoczy, Agnes ;
Pakaski, Magdolna ;
Kalman, Janos ;
Janka, Zoltan .
PSYCHIATRIC GENETICS, 2011, 21 (05) :249-252